Current evidence for osteoarthritis treatments

Therapeutic Advances in Musculoskeletal Disease

Volumn 2, Issue 1, 2010, Pages 17-28

  Anandacoomarasamy, Ananthila ^a   March, Lyn ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

disease modification; management; non pharmacological; osteoarthritis; pharmacological; surgical; symptom modification

Indexed keywords

EID: 84993736162     PISSN: 1759720X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1759720X09359889     Document Type: Review

References (77)

1. Bagga, H., Burkhardt, D., Sambrook, P. and March, L. ( 2006) Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee. J Rheumatol 33: 946-950.
2. Bagge, E., Bjelle, A., Eden, S. and Svanborg, A. ( 1991) Factors associated with radiographic osteoarthritis: results from the population study 70-year-old people in Goteborg. J Rheumatol 18: 1218-1222.
3. Bannwarth, B. ( 2006) Acetaminophen or NSAIDs for the treatment of osteoarthritis. Best Pract Res Clin Rheumatol 20: 117-129.
4. Barnsley, L. ( 2005) How to treat: osteoarthritis. Australian Doctor 18 March: 27-34.
5. Bellamy, N., Campbell, J., Robinson, V., Gee, T., Bourne, R. and Wells, G. ( 2005) Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev CD005321.
6. Bellamy, N., Campbell, J., Robinson, V., Gee, T., Bourne, R. and Wells, G. ( 2006) Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev CD005328.
7. Bingham, C.O., Buckland-Wright, J.C., Garnero, P., Cohen, S.B., Dougados, M., Adami, S. et al. (2006) Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis Rheum 54: 3494-3507.
8. Biswal, S., Medhi, B. and Pandhi, P. ( 2006) Longterm efficacy of topical nonsteroidal antiinflammatory drugs in knee osteoarthritis: metaanalysis of randomized placebo controlled clinical trials. J Rheumatol 33: 1841-1844.
9. Brien, S., Prescott, P., Bashir, N., Lewith, H. and Lewith, G. ( 2008a) Systematic review of the nutritional supplements dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) in the treatment of osteoarthritis. Osteoarthritis Cartilage 16: 1277-1288.
10. Brien, S., Prescott, P., Coghlan, B., Bashir, N. and Lewith, G. ( 2008b) Systematic review of the nutritional supplement Perna Canaliculus (green-lipped mussel) in the treatment of osteoarthritis. QJM 101: 167-179.
11. Brouwer, R.W., Raaij van, T.M., Bierma-Zeinstra, S.M., Verhagen, A.P., Jakma, T.S. and Verhaar, J.A. ( 2007) Osteotomy for treating knee osteoarthritis. Cochrane Database Syst Rev CD004019.
12. Bruyere, O., Delferriere, D., Roux, C., Wark, J.D., Spector, T., Devogelaer, J.P. et al. (2008) Effects of strontium ranelate on spinal osteoarthritis progression. Ann Rheum Dis 67: 335-339.
13. Chevalier, X., Goupille, P., Beaulieu, A.D., Burch, F.X., Bensen, W.G., Conrozier, T. et al. (2009) Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 61: 344-352.
14. Christensen, R., Astrup, A. and Bliddal, H. ( 2005) Weight loss: the treatment of choice for knee osteoarthritis? A randomized trial. Osteoarthritis Cartilage 13: 20-27.
15. Cicuttini, F.M., Baker, J.R. and Spector, T.D. ( 1996) The association of obesity with osteoarthritis of the hand and knee in women: a twin study. J Rheumatol 23: 1221-1226.
16. Cicuttini, F.M., Spector, T. and Baker, J. ( 1997) Risk factors for osteoarthritis in the tibiofemoral and patellofemoral joints of the knee. J Rheumatol 24: 1164-1167.
17. Clegg, D.O., Reda, D.J., Harris, C.L., Klein, M.A., O'Dell, J.R., Hooper, M.M. et al. (2006) Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 354: 795-808.
18. Cohen, J. ( 1988) Statistical power for the behavioral sciences (2nd ed.). The Effect size, Erlbaum: Hillsdale, NJ, pp. 8-14.
19. Dawson, J., Linsell, L., Doll, H., Zondervan, K., Rose, P., Carr, A. et al. (2005) Assessment of the Lequesne index of severity for osteoarthritis of the hip in an elderly population. Osteoarthritis Cartilage 13: 854-860.
20. Deal, C.L., Schnitzer, T.J., Lipstein, E., Seibold, J.R., Stevens, R.M., Levy, M.D. et al. (1991) Treatment of arthritis with topical capsaicin: a double-blind trial. Clin Ther 13: 383-395.
21. Dougados, M., Nguyen, M., Berdah, L., Mazieres, B., Vignon, E. and Lequesne, M. ( 2001) Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip. Arthritis Rheum 44: 2539-2547.
22. Ethgen, O., Bruyere, O., Richy, F., Dardennes, C. and Reginster, J.Y. ( 2004) Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature J Bone Joint Surg Am 86-A: 963-974.
23. Farmer, K.W., Hammond, J.W., Queale, W.S., Keyurapan, E. and McFarland, E.G. ( 2007) Shoulder arthroplasty versus hip and knee arthroplasties: a comparison of outcomes. Clin Orthop Relat Res 455: 183-189.
24. Felson, D.T. ( 2004) An update on the pathogenesis and epidemiology of osteoarthritis. Radiol Clin North Am 42: 1-9, v.
25. Felson, D.T. ( 2006) Clinical practice. Osteoarthritis of the knee. N Engl J Med 354: 841-848.
26. Felson, D.T. ( 2009) Developments in the clinical understanding of osteoarthritis. Arthritis Res Ther 11: 203.
27. Felson, D.T., Anderson, J.J., Naimark, A., Walker, A.M. and Meenan, R.F. ( 1988) Obesity and knee osteoarthritis. The Framingham Study. Ann Intern Med 109: 18-24.
28. Felson, D.T., Zhang, Y., Anthony, J.M., Naimark, A. and Anderson, J.J. ( 1992) Weight loss reduces the risk for symptomatic knee osteoarthritis in women. The Framingham Study. Ann Intern Med 116: 535-539.
29. Felson, D.T., Zhang, Y., Hannan, M.T., Naimark, A., Weissman, B., Aliabadi, P. et al. (1997) Risk factors for incident radiographic knee osteoarthritis in the elderly: the Framingham Study. Arthritis Rheum 40: 728-733.
30. Fransen, M. and McConnell, S. ( 2008) Exercise for osteoarthritis of the knee. Cochrane Database Syst Rev Oct 8 (4): CD004376, Review.
31. Furukawa, T.A. ( 1999) From effect size into number needed to treat. Lancet 353: 1680.
32. Gray, M.L., Burstein, D., Kim, Y.J. and Maroudas, A. ( 2008) 2007 Elizabeth Winston Lanier Award Winner. Magnetic resonance imaging of cartilage glycosaminoglycan: basic principles, imaging technique, and clinical applications. J Orthop Res 26: 281-291.
33. Griffin, T., Rowden, N., Morgan, D., Atkinson, R., Woodruff, P. and Maddern, G. ( 2007) Unicompartmental knee arthroplasty for the treatment of unicompartmental osteoarthritis: a systematic study. ANZ J Surg 77: 214-221.
34. Guermazi, A., Burstein, D., Conaghan, P., Eckstein, F., Hellio Le Graverand-Gastineau, M.P., Keen, H. et al. (2008) Imaging in osteoarthritis. Rheum Dis Clin North Am 34: 645-687.
35. Hart, D.J., Doyle, D.V. and Spector, T.D. ( 1999) Incidence and risk factors for radiographic knee osteoarthritis in middle-aged women: the Chingford Study. Arthritis Rheum 42: 17-24.
36. Harvey, W.F. and Hunter, D.J. ( 2008) The role of analgesics and intra-articular injections in disease management. Rheum Dis Clin North Am 34: 777-788.
37. Hinman, R.S. and Bennell, K.L. (2009) Advances in insoles and shoes for knee osteoarthritis. Curr Opin Rheumatol 21: 164-170.
38. Hogenmiller, M.S. and Lozada, C.J. ( 2006) An update on osteoarthritis therapeutics. Curr Opin Rheumatol 18: 256-260.
39. Hooper, L., Brown, T.J., Elliott, R., Payne, K., Roberts, C. and Symmons, D. ( 2004) The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review. BMJ 329: 948.
40. Hunter, D.J. and Hellio Le Graverand-Gastineau, M.P. ( 2008) How close are we to having structure-modifying drugs available? Rheum Dis Clin North Am 34: 789-802.
41. Jarvinen, K., Vuolteenaho, K., Nieminen, R., Moilanen, T., Knowles, R.G. and Moilanen, E. ( 2008) Selective iNOS inhibitor 1400W enhances anti-catabolic IL-10 and reduces destructive MMP-10 in OA cartilage. Survey of the effects of 1400W on inflammatory mediators produced by OA cartilage as detected by protein antibody array. Clin Exp Rheumatol 26: 275-282.
42. Jordan, K.M., Arden, N.K., Doherty, M., Bannwarth, B., Bijlsma, J.W., Dieppe, P. et al. (2003) EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 62: 1145-1155.
43. Kirkley, A., Birmingham, T.B., Litchfield, R.B., Giffin, J.R., Willits, K.R., Wong, C.J. et al. (2008) A randomized trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med 359: 1097-1107.
44. Laupattarakasem, W., Laopaiboon, M., Laupattarakasem, P. and Sumananont, C. ( 2008) Arthroscopic debridement for knee osteoarthritis. Cochrane Database Syst Rev CD005118.
45. Leopold, S.S. ( 2009) Minimally invasive total knee arthroplasty for osteoarthritis. N Engl J Med 360: 1749-1758.
46. Lin, J., Zhang, W., Jones, A. and Doherty, M. ( 2004) Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. BMJ 329: 324.
47. Loeser, R.F. ( 2006) Molecular mechanisms of cartilage destruction: mechanics, inflammatory mediators, and aging collide. Arthritis Rheum 54: 1357-1360.
48. Lonner, J.H. ( 2003) A 57-year-old man with osteoarthritis of the knee. JAMA 289: 1016-1025.
49. Manicourt, D.H., Azria, M., Mindeholm, L., Thonar, E.J. and Devogelaer, J.P. ( 2006) Oral salmon calcitonin reduces Lequesne's algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis. Arthritis Rheum 54: 3205-3211.
50. McAlindon, T.E. ( 2006) Nutraceuticals: do they work and when should we use them ? Best Pract Res Clin Rheumatol 20: 99-115.
51. McGettigan, P. and Henry, D. ( 2006) Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA 296: 1633-1644.
52. Messier, S.P., Loeser, R.F., Miller, G.D., Morgan, T.M., Rejeski, W.J., Sevick, M.A. et al. (2004) Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: the Arthritis, Diet, and Activity Promotion Trial. Arthritis Rheum 50: 1501-1510.
53. Murphy, L., Schwartz, T.A., Helmick, C.G., Renner, J.B., Tudor, G., Koch, G. et al. (2008) Lifetime risk of symptomatic knee osteoarthritis. Arthritis Rheum 59: 1207-1213.
54. Pelletier, J.P., Martel-Pelletier, J. and Raynauld, J.P. ( 2006) Most recent developments in strategies to reduce the progression of structural changes in osteoarthritis: today and tomorrow. Arthritis Res Ther 8: 206.
55. Pham, T., Maillefert, J.F., Hudry, C., Kieffert, P., Bourgeois, P., Lechevalier, D. et al. (2004 a) Laterally elevated wedged insoles in the treatment of medial knee osteoarthritis. A two-year prospective randomized controlled study. Osteoarthritis Cartilage 12: 46-55.
56. Pham, T., Le, H.A., Ravaud, P., Dieppe, P., Paolozzi, L. and Dougados, M. ( 2004b) Evaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NRD101, in comparison with diacerein and placebo in a 1 year randomised controlled study in symptomatic knee osteoarthritis. Ann Rheum Dis 63: 1611-1617.
57. Poole, A.R. ( 2002) Can serum biomarker assays measure the progression of cartilage degeneration in osteoarthritis? Arthritis Rheum 46: 2549-2552.
58. Qvistgaard, E., Christensen, R., Torp-Pedersen, S. and Bliddal, H. ( 2006) Intra-articular treatment of hip osteoarthritis: a randomized trial of hyaluronic acid, corticosteroid, and isotonic saline. Osteoarthritis Cartilage 14: 163-170.
59. Rains, C. and Bryson, H.M. ( 1995) Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis. Drugs Aging 7: 317-328.
60. Raynauld, J.P., Buckland-Wright, C., Ward, R., Choquette, D., Haraoui, B., Martel-Pelletier, J. et al. (2003) Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 48: 370-377.
61. Reichenbach, S., Sterchi, R., Scherer, M., Trelle, S., Burgi, E., Burgi, U. et al. (2007) Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med 146: 580-590.
62. Richy, F., Bruyere, O., Ethgen, O., Cucherat, M., Henrotin, Y. and Reginster, J.Y. ( 2003) Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Arch Intern Med 163: 1514-1522.
63. Rintelen, B., Neumann, K. and Leeb, B.F. ( 2006) A meta-analysis of controlled clinical studies with diacerein in the treatment of osteoarthritis. Arch Intern Med 166: 1899-1906.
64. Roddy, E. and Doherty, M. ( 2006) Changing life-styles and osteoarthritis: what is the evidence ? Best Pract Res Clin Rheumatol 20: 81-97.
65. Sawitzke, A.D., Shi, H., Finco, M.F., Dunlop, D.D., Bingham, III C.O., Harris, C.L. et al. (2008) The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial. Arthritis Rheum 58: 3183-3191.
66. Scharf, H.P., Mansmann, U., Streitberger, K., Witte, S., Kramer, J., Maier, C. et al. (2006) Acupuncture and knee osteoarthritis: a three-armed randomized trial. Ann Intern Med 145: 12-20.
67. Towheed, T.E., Maxwell, L., Anastassiades, T.P., Shea, B., Houpt, J., Robinson, V. et al. (2005) Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev CD002946.
68. Towheed, T.E., Maxwell, L., Judd, M.G., Catton, M., Hochberg, M.C. and Wells, G. ( 2006) Acetaminophen for osteoarthritis. Cochrane Database Syst Rev CD004257.
69. Verbruggen, G. ( 2006) Chondroprotective drugs in degenerative joint diseases. Rheumatology (Oxford) 45: 129-138.
70. Wasiak, J., Clar, C. and Villanueva, E. ( 2006) Autologous cartilage implantation for full thickness articular cartilage defects of the knee. Cochrane Database Syst Rev 3: CD003323.
71. Weng, H.H. and Fitzgerald, J. ( 2006) Current issues in joint replacement surgery. Curr Opin Rheumatol 18: 163-169.
72. White, A., Foster, N.E., Cummings, M. and Barlas, P. ( 2007) Acupuncture treatment for chronic knee pain: a systematic review. Rheumatology (Oxford) 46: 384-390.
73. Woolf, A.D. and Pfleger, B. ( 2003) Burden of major musculoskeletal conditions. Bull World Health Organ 81: 646-656.
74. Yang, K.G., Raijmakers, N.J., van Arkel, E.R., Caron, J.J., Rijk, P.C., Willems, W.J. et al. (2008) Autologous interleukin-1 receptor antagonist improves function and symptoms in osteoarthritis when compared to placebo in a prospective randomized controlled trial. Osteoarthritis Cartilage 16: 498-505.
75. Zhang, W., Jones, A. and Doherty, M. ( 2004) Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta-analysis of randomised controlled trials. Ann Rheum Dis 63: 901-907.
76. Zhang, W., Doherty, M., Arden, N., Bannwarth, B., Bijlsma, J., Gunther, K.P. et al. (2005) EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 64: 669-681.
77. Zhang, W., Moskowitz, R.W., Nuki, G., Abramson, S., Altman, R.D., Arden, N. et al. (2008) OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 16: 137-162.